Skip to main content
SupplementScience
Ginkgo Biloba supplement
Herbal Extract

Ginkgo Biloba: Benefits, Dosage, Forms & Research

Herbal Extract

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

TL;DR — Quick Answer

Ginkgo biloba (EGb 761) improves cerebral blood flow and provides antioxidant neuroprotection. At 120-240mg daily of standardized extract, it supports memory and may slow cognitive decline in older adults. The most widely prescribed herbal cognitive supplement in Europe.

Key Facts

What it is
A standardized herbal extract from the oldest living tree species, enhancing cerebral blood flow
Primary benefits
  • Improves cerebral blood flow
  • Antioxidant neuroprotection
  • Supports memory in aging adults
  • May reduce tinnitus symptoms
  • Enhances peripheral circulation
Typical dosage
120-240mg standardized extract daily
Evidence level
Moderate
Safety profile
Safe with Caution

What the Research Says

Ginkgo biloba is among the most extensively studied herbal medicines, with hundreds of clinical trials. The large GuidAge trial (n=2,854) found that while ginkgo did not prevent dementia onset in healthy elderly, it reduced risk in a compliant subgroup. A 2014 Cochrane-quality meta-analysis of EGb 761 confirmed modest but statistically significant cognitive benefits in patients with existing cognitive impairment. The GEM trial (n=3,069) in the US found no prevention benefit in healthy elderly. The European medical consensus favors ginkgo as an evidence-based treatment for mild-to-moderate dementia and cognitive decline.

Benefits of Ginkgo Biloba

  • Cerebral blood flow — ginkgo's terpene lactones (ginkgolides) inhibit platelet-activating factor (PAF), improving microcirculation in the brain and periphery
  • Cognitive function in elderly — a 2014 meta-analysis of 21 trials (n=2,608) found EGb 761 at 240mg/day significantly improved cognition and daily function in patients with mild cognitive impairment and dementia
  • Antioxidant neuroprotection — flavonoid glycosides scavenge free radicals and protect neuronal mitochondria from oxidative damage, reducing age-related neuronal loss
  • Tinnitus relief — several European trials show 120-240mg EGb 761 daily reduces tinnitus severity, though results are mixed across studies
  • Peripheral circulation — ginkgo improves blood flow to extremities, benefiting conditions like Raynaud's syndrome and intermittent claudication
Did you know?

Ginkgo biloba is among the most extensively studied herbal medicines, with hundreds of clinical trials.

Forms of Ginkgo Biloba

FormBioavailabilityBest For
EGb 761 Standardized ExtractHighGold standard — 24% flavonoid glycosides, 6% terpene lactones; most clinically studied form
Generic Standardized ExtractModerate-HighBudget option — verify standardization to 24/6 ratio
Whole Leaf CapsulesLow-ModerateTraditional use — lower concentration of active compounds

Dosage Recommendations

General recommendation: 120-240mg daily of standardized extract (24% flavonoid glycosides, 6% terpene lactones)

Timing: Take with meals; divide into 2 doses (morning and afternoon) for sustained effect • Take with food for best absorption.

Dosage by Condition

ConditionRecommended DoseEvidence
Cognitive support240mg dailyModerate
Tinnitus120-240mg daily for 8-12 weeksEmerging
Peripheral circulation120-160mg dailyModerate

Upper limit: 240mg/day of standardized extract

Side Effects and Safety

Safety profile: Safe with Caution

Potential Side Effects

  • Headache (most common, usually transient)
  • Digestive upset, nausea
  • Dizziness
  • Allergic skin reactions (rare — related to ginkgolic acids; quality extracts minimize this)
  • Increased bleeding risk with anticoagulant medications

Drug & Supplement Interactions

  • Anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel) — ginkgo inhibits PAF and may increase bleeding risk
  • NSAIDs — additive bleeding risk
  • Anticonvulsants — ginkgo may reduce seizure threshold in susceptible individuals
  • CYP3A4 and CYP2C9 substrates — potential for pharmacokinetic interactions
  • SSRIs — rare reports of serotonin syndrome when combined
Check Ginkgo Biloba interactions with other supplements →
BenefitsDosage GuideSide EffectsTypes & FormsResearchFAQ

Related Conditions

Brain FogFocus & Cognitive Performance

Related Supplements

PhosphatidylserineBacopa MonnieriVinpocetine

Frequently Asked Questions

Does ginkgo biloba actually work for memory?

The evidence is nuanced. For healthy young adults, ginkgo shows minimal cognitive benefit. For older adults with existing mild cognitive impairment or early dementia, standardized EGb 761 at 240mg/day consistently shows modest improvements in memory, attention, and daily functioning across European trials. It is not a memory miracle pill, but it has real, clinically validated effects in the right population.

Is ginkgo biloba safe with blood thinners?

Ginkgo should be used with caution alongside blood thinners. Its ginkgolides inhibit platelet-activating factor (PAF), which can theoretically increase bleeding risk. While clinical trials have not consistently shown dangerous interactions, most guidelines recommend avoiding the combination or using only under medical supervision. Stop ginkgo at least 2 weeks before surgery.

How long does ginkgo take to work?

Most clinical trials measure outcomes at 8-12 weeks, with some showing initial improvements by 4-6 weeks. Ginkgo works through gradual improvements in cerebral blood flow and antioxidant protection rather than acute stimulation. Consistent daily use for at least 8 weeks is recommended before evaluating effectiveness.

References

  1. (). Efficacy and adverse effects of Ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. Journal of Alzheimer's Disease. DOI
  2. (). Ginkgo biloba for prevention of dementia: a randomized controlled trial (GEM Study). JAMA. DOI
  3. (). Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. The Lancet Neurology. DOI